SCHEMBL18960362

SCHEMBL18960362

CC1(/C=C(\C#N)C(=O)S)COC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18959127 0.84 EPHX1 (0.30) —
SCHEMBL15711190 0.82 EGFR (0.36) —
SCHEMBL18959114 0.82 — —
SCHEMBL15711192 0.82 EGFR (0.36) —
SCHEMBL18959154 0.79 MAPT (0.35) —
SCHEMBL19421183 0.79 MEN1 (0.40) —
SCHEMBL18959132 0.79 — —
SCHEMBL19427232 0.74 — —
SCHEMBL726326 0.63 CD81 (0.30) —
SCHEMBL6351242 0.62 APP (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017100668-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHODS OF THEIR USE JANSSEN PHARMACEUTICA NV (BE) 2017-06-15 — — WO disclosed
Send feedback